Omicron Neutralization after the Third Vaccine Dose Neutralization assays of SARS-CoV-2
pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in …

The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …

In the middle of November 2021, Omicron (B. 1.1. 529), a novel variant of SARS-CoV-2 was
identified in South Africa. Owing to continuous increasing cases with rapid transmissibility …

The evolvement of coronavirus variants is socially unacceptable but understandable in a
world that has grown tired of playing defence against “severe acute respiratory syndrome …

Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies |
Nature Medicine Skip to main content Thank you for visiting nature.com. You are using a …

Antibody-dependent enhancement (ADE) of disease is a general concern for the
development of vaccines and antibody therapies because the mechanisms that underlie …

Discussion There have been over 8.2 billion doses of SARS-CoV-2 vaccines administrated
in more than 4.3 billion persons around the world [Citation 1]. However, the emerging of the …

ABSTRACT COVID-19 is a spectrum of clinical symptoms in humans caused by infection
with SARS-CoV-2. The B. 1.1. 529 Omicron variant is rapidly emerging and has been …

In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two …